White Paper | Intranasal Delivery of Biologic Therapeutics and Vaccines

Intranasal administration of biologic therapeutics has potential to address a wide range of diseases. In this article, David Ward, Formulation and Manufacturing Lead at Intertek Melbourn, looks at how the nasal route of drug administration offers the potential to improve the delivery of biologics and why strategic formulation is required to make this a reality.

Complete the form below to download the whitepaper.